UF Innovate | Tech Licensing Announces Another Successful Partnership with Portfolio Company Entrinsic Health Solutions Inc. (UF News)

University of Florida startup Entrinsic Health Solutions Inc. (EHS), an innovative health sciences company, has entered into a partnership that provides for a worldwide commercial license and supply agreement for enterade®, an amino acid-based, glucose-free, electrolyte solution designed for oncology and gastrointestinal (GI) disease patients. “We are excited about this partnership,” stated Dr. Sadasivan Vidyasagar, […]

Interim Phase II Results of DNX-2401 + Pembrolizumab for Glioblastoma Shows Remarkable Results (Onco’zine)

Preliminary results from the CAPTIVE / KEYNOTE-192 study (NCT02798406) dose escalation study evaluating a single intratumoral injection of DNX-2401 (tasadenoturev; UF startup DNAtrix) followed by standard dosing with pembrolizumab (Keytruda®; Merck Sharp & Dohme Corp/MSD) every three weeks to determine the optimal dose, safety, and efficacy in patients with recurrent glioblastoma, demonstrate that combination of […]

AGTC Posts Quarterly Income (Healio)

UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation reported a net income of $1.2 million for the first quarter of its fiscal year compared with a net loss of $1.4 million in the same quarter of 2017. General and administrative expenses decreased from $3.7 million to $3.2 million, while […]

OxThera AB is Being Granted US Patent for Oxalobacter Secretagogues (PR Newswire)

UF startup OxThera AB, a privately-held Stockholm-based biopharmaceutical company, announced a granted US patent on Oxalobacter formigenes secretagogues. OxThera AB, a spinout of Ixion, is a UF Innovate | Sid Martin Biotech alumnus. Oxabact®, a formulation of highly concentrated lyophilized Oxalobacter formigenes, is being developed by OxThera AB as a potential treatment for patients with […]

Entrinsic Health Solutions and Nestlé Health Science Enter Global Partnership for Novel Amino Acid Product enterade® (BusinessWire)

UF startup Entrinsic Health Solutions (EHS), an innovative health sciences company, announced that they have entered into a partnership with Nestlé Health Science (NHSc), a global innovative leader pioneering premium-quality, science-based nutritional health solutions. The partnership gives NHSc the exclusive rights to market EHS’s enterade® product. This partnership is structured as a worldwide commercial license […]

DNAtrix and Valo Therapeutics Enter into Strategic Partnership to Develop Peptide-Coated Oncolytic Viruses for Treating Cancer (PR Newswire)

UF startup DNAtrix and Valo Therapeutics announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix’s clinical stage viruses and Valo’s proprietary antigenic peptide technology. DNAtrix’s clinical stage oncolytic adenovirus platform and Valo’s PeptiCRAd (Peptide-coated Conditionally Replicating Adenovirus) vaccination technology will be combined to generate a novel “armed oncolytic vaccine” for cancer therapy. While […]

OxThera Presents Encouraging 52-Week Efficacy and Safety Data for Oxabact® in Primary Hyperoxaluria Type 1 (PH1) Patients with ESRD (PR Newswire)

UF startup OxThera AB, a Stockholm-based privately-held biopharmaceutical company and leader in the field of microbiome derived biotherapeutics, announced a poster presentation showing encouraging Oxabact® efficacy and safety data from the long-term study OC5-OL-01, at the Annual Meeting of the American Society of Nephrology Kidney Week 2018 in San Diego. “We are pleased to present […]